Donepezil: all 188 studies that test it
Page 1 of 2. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2511 in Participants With Early Alzheimer's Disease (AD)Not yet recruitingNCT07768592Phase 1
- Acetylcholinesterase Inhibitor in Anorexia Nervosa: Multicenter, Double-Blind, Placebo-Controlled TrialNot yet recruitingNCT06687993Phase 2
- An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia NervosaNot yet recruitingNCT06518941Phase 2
- Effect of Acetylcholinesterase Inhibitors on Bone MetabolismRecruitingNCT06041789Phase 2
- Randomized Clinical Trial of Donepezil for the Treatment of Mild Cognitive Impairment in Parkinson's DiseaseNot yet recruitingNCT05709301Phase 2
- Donepezil Versus Non-drug Treatment in Alzheimer's Disease.RecruitingNCT04661280Phase 3
- The Effect of Donepezil on Wound HealingRecruitingNCT04505670Phase 2
- Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413)CompletedNCT04730635Phase 1Results posted
- Pharmacokinetic Study of 5 and 10 mg Corplex™ Donepezil TDS Compared to 10 mg Aricept® in Healthy VolunteersCompletedNCT04617782Phase 1Results posted
- MK-1942/Donepezil Interactions in Participants With Alzheimer's Disease (MK-1942-005)CompletedNCT04308304Phase 1Results posted
- Monitoring Anti-Dementia Drugs by Serum LevelsCompletedNCT04117178Phase 4Results posted
- A Study in Healthy Men and Women to Test Which Effects Donepezil and BI 425809 Have on Each OtherCompletedNCT03905096Phase 1Results posted
- Detecting an Early Response to Donepezil With Measures of Visual AttentionCompletedNCT03073876Phase 4Results posted
- Phase 3 Randomized Placebo Controlled Clinical Trial of DonepezilCompletedNCT02822573Phase 3Results posted
- Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's DiseaseCompletedNCT02787746Phase 4Results posted
- Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy ParticipantsTerminatedNCT02769065Phase 1Results posted
- A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular DiseaseCompletedNCT02660983Phase 4Results posted
- Investigation of Pharmacokinetic Drug-drug Interaction of BI 409306 and Donepezil in Healthy Male and Female SubjectsCompletedNCT02635750Phase 1Results posted
- A Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's TypeCompletedNCT02549196Phase 2Results posted
- Pilot Study of Sleep Therapy and Biomarkers in Children With Autism Spectrum DisordersTerminatedNCT02487082Phase 2Results posted
- The Impact of Arousal Threshold in Obstructive Sleep ApneaCompletedNCT02264353Phase 4Results posted
- Effects of Cholinergic Augmentation on Measures of Balance and GaitCompletedNCT02206620Phase 2Results posted
- Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's DiseaseCompletedNCT02097056Phase 4Results posted
- Effects of Donepezil HCL on Task-Activated fMRI Brain Activation in Healthy Older Adults at Genetic Risk for Alzheimer's DiseaseCompletedNCT02087865Phase 4Results posted
- Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318)CompletedNCT02064920Phase 2Results posted
- Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy AdultsCompletedNCT02051335Phase 1Results posted
- Olfactory Deficits and Donepezil Treatment in Cognitively Impaired ElderlyCompletedNCT01951118Phase 4Results posted
- A Trial of the Drug Donepezil for Sleep Enhancement and Behavioral Change in Children With AutismTerminatedNCT01887132Phase 2Results posted
- Olfactory Deficits in MCI as Predictor of Improved Cognition on DonepezilCompletedNCT01845636Phase 4Results posted
- Donepezil Compared to Placebo in Patients With Chronic Neuropathic PainTerminatedNCT01743976Phase 4Results posted
- Combination Treatment Study for Memory Impairment and DepressionCompletedNCT01658228Phase 4Results posted
- The Effect of Donepezil on Gait and Balance in Parkinson's DiseaseCompletedNCT01521117Phase 4Results posted
- Study of Donepezil in Female Breast Cancer Survivors With Cognitive DysfunctionCompletedNCT01466270Phase 2Results posted
- Comparative Research of Alzheimer's Disease DrugsTerminatedNCT01362686Not applicableResults posted
- A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension PhaseCompletedNCT01278407Phase 3Results posted
- A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type DementiaCompletedNCT01276353Phase 2Results posted
- 10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Non-Fasting ConditionsCompletedNCT01260948Phase 1Results posted
- 10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions.CompletedNCT01260922Phase 1Results posted
- Effect of Donepezil on SmokingCompletedNCT01250977Phase 2Results posted
- Randomized Controlled Study of Donepezil in Fragile X SyndromeCompletedNCT01120626Phase 2Results posted
- Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's DiseaseTerminatedNCT01082965Not applicableResults posted
- A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive ImpairmentCompletedNCT00934375Phase 4Results posted
- Study in Elderly Alzheimer's Patients to Assess Skin Tolerability, Irritation With 3, 7-Day Applications of DTP-SystemCompletedNCT00916383Phase 2Results posted
- Cholinergic Augmentation in Frequently Falling Subjects With Parkinson's DiseaseCompletedNCT00912808Not applicableResults posted
- Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's DiseaseCompletedNCT00911807Phase 2Results posted
- A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)TerminatedNCT00874939Phase 1Results posted
- Mayo Acute Stroke Trial for Enhancing RecoveryCompletedNCT00805792Phase 2Results posted
- Corticolimbic Degeneration and Treatment of DementiaCompletedNCT00768261Phase 4Results posted
- Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17TerminatedNCT00754052Phase 3Results posted
- Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10TerminatedNCT00754013Phase 3Results posted
- The Effect of Donepezil (Aricept(Registered Trademark)) on REM Sleep in Children With AutismCompletedNCT00695136Phase 1/2Results posted
- Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer TreatmentCompletedNCT00688376Phase 3Results posted
- Evaluating The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled TrialTerminatedNCT00675025Phase 2Results posted
- Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic NeuropathyTerminatedNCT00619983Phase 4Results posted
- A Long-term, Extension Study of E2020 in Patients With Dementia With Lewy BodiesCompletedNCT00598650Phase 2Results posted
- Supporting the Health of Adults Undergoing Orthopedic Surgery During the Recovery PeriodCompletedNCT00586196Phase 2Results posted
- The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living FacilityCompletedNCT00571064Phase 4Results posted
- Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (HCl) (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down SyndromeCompletedNCT00570128Phase 2Results posted
- Open-Label Extension Study of 23 mg Donepezil SR in Participants With Moderate to Severe Alzheimer's DiseaseCompletedNCT00566501Phase 3Results posted
- A Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Study E2020-J081-431)CompletedNCT00543855Phase 2Results posted
- Impact of Cholinesterase Inhibitors on Driving Ability in Healthy Older AdultsCompletedNCT00482001Phase 4Results posted
- Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's DiseaseCompletedNCT00478205Phase 3Results posted
- Neural Correlates In Mild Alzheimer's DiseaseCompletedNCT00477659Phase 4Results posted
- Use of Donepezil for Treatment of Cocaine DependenceCompletedNCT00467389Phase 2Results posted
- Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the BrainCompletedNCT00452868Early Phase 1Results posted
- The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's DiseaseCompletedNCT00381381Phase 4Results posted
- Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain TumorsCompletedNCT00369785Phase 3Results posted
- The Effect of Donepezil on Sedation and Other SymptomsTerminatedNCT00352664Phase 3Results posted
- Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a StrokeCompletedNCT00227994Phase 4Results posted
- Antidepressant Medication Plus Donepezil for Treating Late-life DepressionCompletedNCT00177671Phase 4Results posted
- Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed DementiaTerminatedNCT00174382Phase 3Results posted
- Donepezil HCl & Cognitive Deficits in AutismCompletedNCT00047697Phase 2Results posted
- Pharmacokinetic Study of GB-5001A 280 mg Long Acting Injection, in Comparison With the Comparator Drug Aricept® 5 mg and Aricept® 10 mg Film-coated Tablet in Healthy SubjectsCompletedNCT07799090Phase 1
- Efficacy of Donepezil in Patients With Chronic TinnitusActive, not recruitingNCT07153991Phase 4
- Investigating the Cholinergic Contribution to Gait Dysfunction in Parkinson's DiseaseCompletedNCT06903910Phase 2
- Phenserine on the Alzheimer's Treatment Horizon, Study 1CompletedNCT06774261Phase 1
- Donepezil Prevents Urinary Retention After Extensive Total HysterectomyStatus unknownNCT05540977Early Phase 1
- Effect of Donepezil on Speech Recognition in Cochlear Implant UsersCompletedNCT05438264Early Phase 1
- Donepezil for Oxaliplatin-induced Neuropathy Peripheral Neuropathy: Proof of Concept StudyCompletedNCT05254639Phase 2
- Efficiency of Donepezil in Elderly Patients for Prevention of POCD DysfunctionStatus unknownNCT04423276Phase 4
- Brain Correlates of Multimodal Rehabilitation in Chronic Post-stroke AphasiaCompletedNCT04134416Phase 3
- The Effect of Donepezil in Radiotherapy-related Cognitive Impairment.Status unknownNCT03907371Phase 2
- A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male VolunteersCompletedNCT03698695Phase 1
- Improving Walking Automaticity in Parkinson's Disease: Levodopa or DonepezilCompletedNCT03599726Early Phase 1
- A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS)CompletedNCT03438604Phase 1
- A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) Applied to Different Body LocationsCompletedNCT03432195Phase 1
- A Skin Irritation Assessment of Once-Weekly Corplex™ Donepezil Transdermal Delivery SystemCompletedNCT03397862Phase 1
- A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept®CompletedNCT03259958Phase 1
- A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's DiseaseCompletedNCT03197740Phase 3
- Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's DiseaseStatus unknownNCT03090516Phase 2/3
- Effect of Acetylcholinesterase Inhibitors on the Gait of the Patients With Parkinson DiseaseStatus unknownNCT03011476Phase 4
- Memory and Mental Health in AgingCompletedNCT02988908Phase 4
- A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®CompletedNCT02968719Phase 1
- Donepezil Attenuate Postoperative Cognitive DysfunctionStatus unknownNCT02927522Phase 3
- A Multidisciplinary Approach to Manage Gait Difficulty in Parkinson PatientsWithdrawnNCT02857244Phase 2
- Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).CompletedNCT02695004Phase 1
- Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23mgCompletedNCT02550665Phase 3
- Effect of Donepezil on Cognition in Parkinson's Disease With Mild Cognitive Impairment (PD-MCI)Status unknownNCT02450786Phase 2
- The Efficacy and Safety Study of High Dose Donepezil in Parkinson's Disease With DementiaStatus unknownNCT02415062Phase 2
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3